You are here:
Health Assessment Document for Trichloroethylene Synthesis and Characterization (2001, External Review Draft)
Federal Register Notices
Notice - This site contains archived material(s)
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the NCEA Webmaster for assistance. Please visit http://epa.gov/ncea to access current information.
For effects other than cancer, an oral reference dose (RfD) of 3x10-4 mg/kg-d was based on critical effects in the liver, kidney, and developing fetus. An inhalation reference concentration (RfC) of 4x10-2 mg/m3 was based on critical effects in the central nervous system, liver, and endocrine system. Several cancer slope factors were developed, with most between 2x10-2 and 4x10-1 per mg/kg-d. Several sources of uncertainty have been identified and quantified.
The mechanistic information suggests some risk factors that may make some populations more sensitive. There are suggestions that TCE could affect children and adults differently. In addition, several chemicals have the potential to alter TCE's metabolism and clearance and subsequent toxicity, conversely, TCE exposure can augment the toxicity of other chemicals. Widespread environmental exposure to some of TCE's metabolites makes it important to consider the cumulative effect of TCE along with other environmental contaminants.
This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.
- (153 pp, 1 MB, about PDF)